Koninklijke Philips N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 17 mrt 2008 - 08:34

Statutaire naam Koninklijke Philips N.V.

Titel Philips announces completion of respironics acquisition

Bericht March 17, 2008 PHILIPS ANNOUNCES COMPLETION OF RESPIRONICS ACQUISITION Amsterdam, The Netherlands and Murrysville, Pennsylvania, USA —Royal Philips Electronics (NYSE:PHG, AEX:PHI) (“Philips”) and Respironics, Inc. (NASDAQ:RESP) (“Respironics”) today announced that Philips has completed the acquisition of Respironics through the merger of its indirect wholly owned subsidiary with and into Respironics. As a result of the merger, Respironics has become an indirect wholly owned subsidiary of Philips. As of March 10, 2008, Respironics’ financial results will be accounted for in the financial results of Philips Healthcare. With the completion of the Respironics acquisition, Philips has rounded off an active period of acquisitions in its Philips Healthcare sector. In addition to Respironics, Philips Healthcare has also recently completed the acquisitions of clinical IT companies VISICU Inc. and Emergin, Inc. As a result, Philips provisionally anticipates acquisition and integration charges related to the Respironics, Visicu and Emergin acquisitions of approximately EUR 200 million for 2008, of which approximately EUR 100 million is expected to impact Philips’ 2008 EBITA. Philips expects to book approximately EUR 40 million of the acquisition and integration charges in the first quarter of 2008, of which approximately EUR 25 million will impact Philips’ first quarter 2008 EBITA. Respironics has requested that NASDAQ file a Form 25 with the United States Securities and Exchange Commission causing the delisting of Respironics’ common stock from NASDAQ and the deregistration of its common stock under the United States federal securities laws. For further information, please contact: Joon Knapen Philips Corporate Communications Tel: +31 20 59 77477 Email: joon.knapen@philips.com Andre Manning Philips Healthcare Tel: +1 646 508 4545 Email: andre.manning@philips.com Dan Bevevino Vice President & CFO, Respironics Tel: +1 724 387 5235 Maryellen Bizzack

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

200803170000000010_2008-03-17 no. 22 Philips announces completion of Respironics acquisition.DOC (opens in a new window)

Datum laatste update: 16 juli 2025